Tick-Borne Encephalitis Vaccine from United States
FSME-Immun is an inactivated tick-borne encephalitis vaccine produced from the virus cultured in chick embryo cells. It is used to protect against tick-borne encephalitis in endemic regions of Europe and Asia. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine obtained by biotechnological processes.
Duty Rate — United States → Canada
0%
Import Tips
• Verify that the vaccine is authorized by Health Canada or obtain a Special Access Programme (SAP) approval
• Provide a certificate of analysis confirming the inactivation process
• Maintain the cold chain at 2-8°C and document temperature data